Skip to main content
Pankit Vachhani, MD, Oncology, Birmingham, AL, University of Alabama Hospital

PankitJaysukhVachhaniMD

Oncology Birmingham, AL

Hematologic Oncology

Physician

Overview of Dr. Vachhani

Dr. Pankit Vachhani is an oncologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including University of Alabama Hospital and USA Health University Hospital. He received his medical degree from Weill Cornell Medical College in Qatar and has been in practice 5 years. He is one of 65 doctors at University of Alabama Hospital and one of 37 doctors at USA Health University Hospital who specialize in Oncology. He has more than 50 publications and over 500 citings.

Education & Training

  • University at Buffalo
    University at BuffaloFellowship, Hematology and Medical Oncology, 2018
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2012 - 2015
  • Weill Cornell Medical College in Qatar
    Weill Cornell Medical College in QatarClass of 2012

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2018 - 2024
  • VA State Medical License
    VA State Medical License 2012 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience  
    Pankit Vachhani, Evelena P Ontiveros, Leukemia Research
  • Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience  
    Pankit Vachhani, Evelena P Ontiveros, Leukemia Research

Abstracts/Posters

  • Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE¬ (Bispecific T-Cell Engager) in Patients with R...
    Pankit Vachhani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
    Pankit Vachhani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Quantification of Humoral Immune Response to Influenza Vaccination in MDS 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Authored Content

  • Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center ExperienceOctober 2018

Press Mentions

  • UAB Named Center of Excellence in Mast Cell Diseases
    UAB Named Center of Excellence in Mast Cell DiseasesFebruary 1st, 2023

Hospital Affiliations